-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$60.0017.58% Upside
IRadimed Corporation Frequently Asked Questions
-
What analysts cover IRadimed Corporation?
IRadimed Corporation has been rated by research analysts at Roth Capital, Loop Capital Markets in the past 90 days.